News & Resources

HOME

/

Congress Video

Adjuvant Abemaciclib Combined with Endocrine Therapy (ET): Efficacy Results in monarchE Cohort 1

Published: 19 May 2022

Adjuvant Abemaciclib Combined with Endocrine Therapy (ET): Efficacy Results in monarchE Cohort 1

MonarchE efficacy presentation from ESMO Breast Cancer 2022, Berlin

Licensed with permission from the European Society for Medical Oncology (ESMO). All rights reserved.

The mention of any company, product, service, or therapy in this collection of materials does not constitute an endorsement of any kind by ESMO.

Sign up for new content alerts

Enter your email address below and we'll contact you as soon as new content is launched!


    Login / register

    "*" indicates required fields

    Consent*
    Healthcare Professional